“The second quarter saw a healthy improvement in the demand for Non-COVID business across all segments. The Company managed to enhance its
Vijaya Diagnostic: A King in the Making
Categories
Health Care
Shalby Ltd. Q2FY23; 71% Growth in Profits
Shalby Ltd.‘s revenues in Q2FY23 rose 11% to ₹ 2,018 millions. Consolidated Profit After Tax came at ₹ 184 millions showcasing a
Shalby Limited: A Rising Star?
“With all key strategies in place, our team is extremely committed to flawless execution of these strategies. Shalby is very well poised
All that you need to know about the Turnaround story of Venus Remedies Ltd
Would you buy the stocks of the company that is loaded in debt, entangled in legal battles and generating crores of loss
Marksans Pharma Limited Q2 FY23 Earnings Conference Call Insights
Key highlights from Marksans Pharma Limited (MARKSANS) Q2 FY23 Earnings Concall Q&A Highlights: [00:12:45] Madhav Shastri asked about the new acquisition made
Orchid Pharma Ltd Q2 FY23 Earnings Conference Call Insights
Key highlights from Orchid Pharma Ltd (ORCHPHARMA) Q2 FY23 Earnings Concall Q&A Highlights: [00:05:20] Rupesh Jain from Intelsense Capital asked about capacity
IOL Chemicals and Pharmaceuticals Limited Q2 FY23 Earnings Conference Call Insights
Key highlights from IOL Chemicals and Pharmaceuticals Limited (IOLCP) Q2 FY23 Earnings Concall Q&A Highlights: [00:12:26] Venkat of 3Sigma Financials asked about
Aarti Industries Ltd Q2 FY23 Earnings Conference Call Insights
Key highlights from Aarti Industries Ltd (AARTIIND) Q2 FY23 Earnings Concall Management Update: [00:03:50] AARTIIND said it is seeing slower demand for
Everything You Need to Know About Brooks Laboratories Limited(NSE:BROOKS)| Stock UP 30% in 2 Months
Brooks Laboratories Limited(NSE:BROOKS) has an industry presence of nearly two decades now, leading to established relationships with the customers as well as
Infographic : Brooks Labrotories (NSE : BROOKS) | Q4FY22 Results Released! | Revenue UP 94.55% YoY
Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both
Infographic : Brooks Labrotories (NSE : BROOKS) | Q1 Results Released! | Revenue DOWN 23.21% YoY
Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both
JB Chemicals & Pharmaceuticals Limited Q2 FY23 Earnings Conference Call Insights
Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q2 FY23 Earnings Concall Management Update: [00:06:28] JBCHEPHARM said that in domestic markets
Biocon Limited Q2 FY23 Earnings Conference Call Insights
Key highlights from Biocon Limited (BIOCON) Q2 FY23 Earnings Concall Q&A Highlights: [00:23:49] Prakash Agarwal of Axis Capital asked about the mezzanine
IOL Chemicals and Pharmaceuticals Limited (IOLCP) Q2 FY23 Earnings Concall Transcript
IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Sanjay Chaturvedi -- Executive Director and Chief Executive
FDC Ltd (FDC) Q2 FY23 Earnings Concall Transcript
FDC Ltd (NSE:FDC) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Varsharani Katre -- Company Secretary and Compliance Officer Sanjay Jain -- Chief Financial Officer Unidentified
Aarti Industries Ltd (AARTIIND) Q2 FY23 Earnings Concall Transcript
Aarti Industries Ltd (NSE:AARTIIND) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Rajendra V. Gogri -- Chairman and Managing Director
Aurobindo Pharma Q2FY23; 41% Fall in Profits
Aurobindo Pharma Ltd.‘s revenue in Q2FY23 fell 3% to ₹ 5,739 crores. Consolidated Profit came at ₹ 409 crores showcasing a 41%
Biocon Limited (BIOCON) Q2 FY23 Earnings Concall Transcript
Biocon Limited (NSE: BIOCON) Q2 FY23 Earnings Concall dated Nov. 14, 2022 Corporate Participants: Saurabh Paliwal -- Head, Investor Relations Kiran Mazumdar
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q2 FY23 Earnings Concall Transcript
JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Q2 FY23 Earnings Concall dated Nov. 14, 2022 Corporate Participants: Jason D'Souza -- Vice President of Investor Relations Nikhil Chopra -- Chief
Glenmark Pharmaceuticals Limited (GLENMARK) Q2 FY23 Earnings Concall Transcript
Glenmark Pharmaceuticals Limited (NSE: GLENMARK) Q2 FY23 Earnings Concall dated Nov. 13, 2022 Corporate Participants: Utkarsh Gandhi -- General Manager - Investor Relations Brendan
Aurobindo Pharma Limited (AUROPHARMA) Q2 FY23 Earnings Concall Transcript
Aurobindo Pharma Limited (NSE: AUROPHARMA) Q2 FY23 Earnings Concall dated Nov. 13, 2022 Corporate Participants: Deepti Thakur -- Investor Relations Santhanam Subramanian -- Chief Financial Officer